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SUMMARY
Metabolic homeostasis is achieved by complex molecular and cellular networks that differ
significantly among individuals and are difficult to model with genetically engineered lines of
mice optimized to study single gene function. Here, we systematically acquired metabolic
phenotypes by using the EUMODIC EMPReSS protocols across a large panel of isogenic but
diverse strains of mice (BXD type) to study the genetic control of metabolism. We generated and
analyzed 140 classical phenotypes and deposited these in an open-access web service for systems
genetics (www.genenetwork.org). Heritability, influence of sex, and genetic modifiers of traits
were examined singly and jointly by using quantitative-trait locus (QTL) and expression QTL-
mapping methods. Traits and networks were linked to loci encompassing both known variants and
novel candidate genes, including alkaline phosphatase (ALPL), here linked to hypophosphatasia.
The assembled and curated phenotypes provide key resources and exemplars that can be used to
dissect complex metabolic traits and disorders.
INTRODUCTION
Energy homeostasis is the result of a tight balance between energy intake and expenditure.
Metabolic disorders, such as obesity and type 2 diabetes, often result when this equilibrium
is disturbed by complex interactions between genetic and environmental factors (Auwerx,
2006). Predisposition to complex diseases such as the metabolic syndrome is inherited in a
non-Mendelian fashion, emphasizing genetic heterogeneity and complex gene-by-
environment interactions (GXE) in pathogenesis. Genetically engineered mouse models are
not ideal for dissecting polygenic networks or GXE interactions precisely because they have
been optimized to study actions of single genes on single genetic backgrounds (Auwerx et
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al., 2004). In contrast, studies in humans have identified risk factors for developing
metabolic diseases with both environmental (e.g., lack of exercise) and genetic causes (e.g.,
mutations in the FTO locus [Dina et al., 2007]), but these studies typically fall short of
defining GXE due to an inability to control environmental influences, cohort and admixture
effects, difficulty in obtaining certain types of physiological and molecular data, and the
inability to sample many individuals with identical genomes under different conditions.
Effective population-based experimental methods to dissect intricate GXEs are needed to
model complex genetically admixed human populations.
Over the past decades, study designs have been optimized to analyze genetic factors in large
populations of naturally divergent strains, chiefly in Mus musculus, Saccharomyces
cerevisiae (Brem et al., 2002; Ehrenreich et al., 2010), Drosophila (King et al., 2012), and
more recently, Caenorhabditis elegans (Andersen et al., 2012). Murine genetic reference
populations (GRPs) are among the best-established mammalian models with which to study
GXE. These GRPs are typically sets of inbred strains that have been assembled to
incorporate carefully titered levels of genetic complexity that model aspects of human
populations. The recombinant inbred (RI) strain families are a type of GRP that enable tight
experimental control, where each genotype is represented by an entire isogenic line, thereby
enabling extensive replication studies (Singer et al., 2004; Williams et al., 2001). The BXD
family, currently the largest and best characterized mouse GRP, is composed of ~160 lines
that descend from crosses between C57BL/6J and DBA/2J, hereafter referred to as B and D,
respectively (Peirce et al., 2004). GRPs such as the BXDs have been bred for quantitative
trait loci (QTL) analyses, a suite of statistical genetic techniques that define regions of the
genome (intervals or loci) and their modulating effects on phenotype. Another major
advantage of GRPs is that high-density genotype data are publicly available. These
genotypes can be combined with full-sequence data of the parental strains to simplify QTL
mapping and identify causal sequence variants (Mozhui et al., 2008; Wang et al., 2010).
Furthermore, owing to the relatively fixed genotypes of GRPs, massive databases of
phenotypes and expression data can be assembled and shared across time, allowing for rapid
multiscalar analyses. Over the last two decades, the BXD family has been exploited mainly
to study the genetics of immune function and infectious disease (Bystrykh et al., 2005;
Miyairi et al., 2007) and in behavioral and neuropharmacological research (Chesler et al.,
2005; Gaglani et al., 2009; Laughlin et al., 2011; Philip et al., 2010). However, few
metabolic phenotypes have been previously generated.
In the present metabolic survey, we systematically generated quantitative data for 140
standardized phenotypes, including glucose response, body weight change, physical activity,
and oxygen consumption across a large subset of the BXD family by using adult males and
females. All data are publicly available as a resource to the scientific community and
complement massive expression data for key cells, tissues, and organs that we and others
have deposited in the GeneNetwork database (www.genenetwork.org; see BXD phenotypes
found under search term “LISP1”). These essential baseline clinical phenotypes are widely
variable, often highly heritable, and in many cases can be linked to genetic loci
encompassing known and novel candidate genes. Heritability and sex effects were highly
variable among traits. Variation in one key trait, alkaline phosphatase, was linked to
hypophosphatasia in lines containing the C57BL/6 allelic variant. Downstream of this
hypophosphatasia, differences in bone structure were noted, as well as a significant increase
in pyridoxal-phosphate (PLP) levels and a corresponding decrease in pyrixodal levels. This
study validates the use of GRPs as a powerful resource to study metabolic homeostasis and
identifies new candidate genes for disease.
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RESULTS
Optimization Study Design for Genetics of Metabolism
Mendelian traits such as coat color can be accurately measured with a sample size of one per
genotype. In contrast, complex metabolic traits with lower heritability benefit greatly from
larger sample sizes per genotype. One of the advantages of GRPs over noninbred yet
genetically diverse strain populations (such as an F2 intercross) is that the heritability of a
trait can be accurately measured and effectively boosted by repeatedly resampling cohorts of
isogenic individuals of the same genotype and sex (Figure 1A). The observed variability
within isogenic strains is thus primarily environmental, whereas differences among strains
are largely genetic. A first step in experimental designs using GRPs is to estimate
heritability and the sample size required to accurately measure a phenotype in a specific
environment. Such calculations provide both a justifiable number of replicates per genotype
and the total numbers of genotypes needed to reliably discriminate gene loci by using QTL-
mapping methods. When traits have high heritability, increasing the number of genotypes
(i.e., strains) greatly improves the power and precision with which QTLs can be mapped,
whereas increasing the number of cases per genotype has almost no impact (Figure 1B, top).
In the case of a Mendelian trait such as coat color, mutations in the brown (Tyrp1) and dilute
(Myo5a) genes explain nearly all variation in pigmentation in the BXD family and map with
peak LOD scores above 25 at these genes (Geisert et al., 2009). In contrast, complex
diseases, including virtually all metabolic disorders, are polygenic, more dependent on
environmental influences, and typically have a nearly normal distribution across genotypes.
Power analysis shows that a study using 20 BXD strains with four animals per genotype will
often detect loci that explain 50% or more of the genetic variance of a moderately heritable
trait, whereas a study using ~40 strains will typically detect loci responsible for ~30% of the
variance (Figure 1B, bottom).
We phenotyped a set of 43 strains—24 strains with male and female animals, 18 strains only
with males, and 1 strain only with females (Figure 1C). Phenotyping was initiated at 13
weeks of age, and all cases underwent seven testing categories (Figures 1C and 1D).
Mapping power was estimated as a function of heritability and sample size. We defined
heritability as the ratio of the within-strain variance to total sample variance (Figure 1D).
Most parameters have moderate to high heritability (h2), averaging 0.67. The more heritable
a trait, the higher the likelihood it will map to significant QTLs (Lynch and Walsh, 1998).
Under the tightly controlled environmental conditions in our vivarium, both glucose
tolerance and blood pressure had h2 ~0.7. Consistent with these moderately high values,
each of these traits was associated with at least one significant locus. In the case of blood
pressure, we have defined a strong candidate gene—UBP1—by using a human genome-
wide association study (GWAS) as a cross validation cohort (Koutnikova et al., 2009).
The BXD GRP allows complementary forward and reverse genetic methods to analyze
metabolic traits (Figure 1E). Conventional forward-mapping methods start with heritable
differences in phenotype and define loci and sequence variants (Figures 1E and S1A
available online). Reverse genetics starts from defined candidate genes and identifies
downstream phenotypic effects (Figures 1E and S1B) (Thomas et al., 2009; Yamamoto et
al., 2011). Because full-sequence data are available for both parental strains of the BXD
family, reverse methods can now be applied genome-wide by using a standard mapping
population. In this resource, we demonstrate both approaches to the data.
The BXD Family Has Wide Variation in Metabolic Traits
Metabolic traits vary to a remarkable degree among the BXD strains, with every trait
showing significant variation (Figure 2A). The least variable trait, basal body temperature,
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varied significantly (from 35.8 ± 0.3 °C in BXD34 to 38.9 ± 0.2 °C in BXD95) despite an
overall variation of less than 1.1-fold. The most variable trait, alkaline phosphatase (ALPL)
protein activity level, varied 6.5-fold between BXD31 (44 ± 11 U/l) and BXD90 (287 ± 18
U/l). For the majority of traits, the distribution of phenotypes is continuous and
approximately normal in both sexes.
As expected, sex differences are a significant source of variance (Champy et al., 2004), with
the more variable traits more likely to exhibit significant sexual dimorphism (Figure 2B).
Traits can be divided into four categories in terms of the significance of variation and
correlations between sexes. Nearly 60% of traits had no significant sex differences. These
traits fall into two categories: those without tight male-female correlation (e.g., shortening
fraction in Figure 2C) and those with it (e.g., red blood cell volume in Figure 2D). The first
category, with no significant sex differences and without strong correlation between males
and females, indicates phenotypes where variation cannot be reliably attributed to genetic
factors (i.e., variation is due to environmental or technical influence) or that there is a strong
sex-by-strain interaction effect. In the case of the shortening fraction, we suspect the former
factor as the cause of the low heritability (h2 = 0.5) of this trait (Figure 2C). In contrast, the
traits with strong correlations between sexes indicate that the genetic variability is not
affected greatly by the environment, and thus the slope of the correlation is close to 1
(Figure 2D).
The remaining 40% of traits exhibit significant differences between males and females, and
again with or without strong male-female correlation. The most striking example is body
weight, with a dramatic difference between males and females, but without consistency
across strains: e.g., BXD75 males are the leanest, whereas the BXD75 females are in the
middle range of body weights (Figure 2E). Lastly, a few traits had both significant sex-
associated differences and strong genetic correlation—one of them being discussed in Figure
4.
QTLs Link Phenotypes to Causal Loci
The data sets generated consist of both general blood parameters, such as hematocrit and
iron levels, and physical phenotypes, such as heart rate and oxygen consumption. Suggestive
or significant QTLs were detected for nearly 40% of all phenotypes (Table S1). Traits with
the highest heritability and the most significant QTLs usually mapped to a single locus.
These traits are exemplified by the tissue-nonspecific (liver/bone/kidney) ALPL (also
commonly known as TNSALP) protein activity, a trait for which 58% of the variance is
explained by the single peak QTL (Figure 3A). Many other traits, including most classical
phenotypes, map to several suggestive or significant loci. In these cases, oligogenic or
polygenic networks of unlinked loci influence trait variance. One good example is basal
oxygen consumption (VO2), a trait for which three loci independently contribute to
phenotypic variation—21% for the most significant locus on Chr1, 18% for the locus on
Chr4, and 8% for the locus on Chr11 (Figure 3B).
Genes located within QTLs were examined for known links to function by using PubMed
and GeneRIF (Mitchell et al., 2003). All but one of the top ten QTLs contained at least one
strong positional and functional candidate (Figure 3C). In some cases, the positional
candidate is well established as the causative gene behind the QTL. This is best illustrated
by hematocrit levels, which map to a locus containing the hemoglobin gene (Popp, 1962). In
other cases, the candidates are linked more tentatively. For example, the QTL for bone
surface area contains the steroid 5 alpha-reductase 1 (Srd5a1) gene, which has been linked to
bone mass in a recent study on Srd5a1 knockout mice (Windahl et al., 2011).
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Genetic Polymorphisms Underlying Variation in ALPL Levels Contribute to Changes in
Bone and Vitamin B6 Homeostasis
Serum ALPL levels are strongly variable among BXD strains, with females having
significantly higher expression (but less variation) than males (Figures 4A and S2A).
Expression of Alpl mRNA in the liver is also highly variable but does not differ by sex
(Figures 4A and S2B) (Gatti et al., 2007). Interestingly, both Alpl mRNA and ALPL protein
activity are highly correlated by strain, regardless of the sex of the animal (Figure 4B),
suggesting strong genetic modulation and a sex effect shared by all strains. Data for ALPL
activity in males and females map to a common QTL: an 11 Mb region of Chr4 (Figure 4C)
that has already been reported in an F2 cross between C57BL/6 and DBA/2 mice (Foreman
et al., 2005). Alpl mRNA also map to the same region (Figure 4C). This QTL harbors ~100
genes, including the Alpl gene itself. We hypothesized that differences in ALPL activity are
primarily and perhaps almost exclusively caused by one or more allelic differences in the
cognate Alpl gene, i.e that this is a so-called cis-regulated expression QTL (cis eQTL).
Rapid identification of all sequence variants in the region was performed by using a mouse
SNP database (www.genenetwork.org). Of 11 exonic SNPs that differentiate B and D
haplotypes of Alpl, nine cause synonymous mutations and two cause missense mutations in
exon 9, resulting in amino acid changes of R318Q and L324P (Figure S2C). We modeled
the impact of these mutations on ALPL protein structure by using Phyre2
(www.sbg.bio.ic.ac.uk/phyre2/) (Figure 4D). Although these mutations are not located in the
active site of ALPL (around S110) (UniProt Consortium, 2012), they are predicted to change
the β sheet/α-helix structure (R318Q and L324P are in green in Figure 4D, showing the
described excerpt of ALPL ± 21 amino acids). Remarkably, mouse and human ALPL
protein sequences share 93%/97% identity/homology. In particular, the region harboring the
two SNPs is highly conserved in vertebrates—notably proline 324 is invariant in other
vertebrates, except in C57BL/6 where it has mutated into leucine (Figure 4E, same excerpt
as in 4D). Moreover, the high degree of conservation of the ALPL protein is also revealed
by phylogenetic tree analysis—human ALPL has 77%/87% sequence identity/homology
with zebrafish ALPL, 44%/61% with D. melanogaster, and 32%/45% with E. coli (Figure
4E). ALPL orthologs separate into three clusters: vertebrates, insects, and bacteria (Figure
4F). Given this high genetic conservation, it is likely ALPL has functions in vertebrates that
are wholly unrelated to bone structure.
In humans, mutations in the ALPL gene can cause varying degrees of hypophosphatasia
(Mornet, 2008), a disorder nearly always associated with the accumulation of
phosphoethanolamine (PEA) in the urine, extracellular pyridoxal-5′-phosphate (PLP) in the
blood, and extracellular inorganic pyrophosphate (PPi) in urine and blood. Downstream of
these biomarkers are many pathways involved in bone remodeling (Whyte, 2000), amino
acid metabolism, and neurotransmitter regulation (Lehninger et al., 2008). Therefore, we
examined patterns of segregation of phenotypes among BXDs by testing several strains with
either the B allele (C57BL/6, BXD48, BXD65, BXD68, BXD75, and BXD103) or the D
allele of Alpl (DBA/2, BXD89, BXD90, and BXD95). We first reconfirmed that ALPL
enzymatic activity was different among strains carrying the alleles (Figure 5A). As
predicted, extracellular PLP levels were strongly negatively correlated with ALPL in both
sexes, supporting the hypothesis that the BXDs are a good model for hypophosphatasia
(Figure 5B). Furthermore, ALPL levels did not correlate with levels of calcium or phosphate
(Pi) (Figure S3A), consistent with studies in humans differentiating hypophosphatasia from
rickets and osteomalacia (Whyte, 2000). Femur bone structure evaluated via micro
computed tomography (microCT) indicated decreased bone area and volume in females with
the B allele of Alpl (Figure 5C), with no difference in overall animal weight between
cohorts (p = 0.76). The same tendency was also noted for males (Figure S3B). Together
these data suggest that the BXD strains are a useful model for hypophosphatasia.
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It is very plausible that the differential regulation of PLP (Figure 5B) by ALPL drives
further phenotypic changes (Figure 5D). PLP acts as a cofactor in many important
biochemical reactions: principally, it is a required prosthetic group for all aminotransferases,
suggesting a critical role in amino acid metabolism (Lehninger et al., 2008), and it is also an
essential coenzyme for biosynthesis of heme (Astner et al., 2005). Confirmation of this link
between ALPL over PLP to amino acid and hematological parameters warrants future work.
Wide Variation in Glucose Response Identifies Genetic Factors of Diabetes
Analysis of complex metabolic phenotypes also yielded QTLs with promising candidates.
One such phenotype is glucose response during intraperitoneal glucose tolerance test
(IPGTT), which records glycaemia levels before and 15, 30, 60 and 120 min after glucose
injection and the overall glucose excursion curve (AUC). The AUC is significantly higher in
males (Figure 6A) but correlates between the sexes (Figure 6B and Table S2A). The AUC is
also linked to physical parameters such as body weight and composition in males, but
surprisingly, not in females (Figure 6B and Tables S2B and S2C), perhaps partly explained
by the fact that fewer female strains were studied. These results show that variation in
glucose response is significantly determined by genetics and partly sex independent.
Consistent with these observations, mapping QTLs for glucose levels during IPGTT
revealed both common and distinct loci in both sexes (Figure S4).
All genes under the four significant or suggestive QTLs for female glucose response on
Chrs1, 2, 7 and 9 (Figure 6C) were investigated. The locus on Chr1 was associated with late
glucose response, with glycaemia at 120 min giving the highest LOD score (Figure 6C).
Within this locus, two genes are associated with type 2 diabetes susceptibility in humans:
cytosolic phospholipase A2 group IV gene (Pla2g4a) and prostaglandinendoperoxide
synthase 2 (Ptgs2, previously known as Cox2), both involved in prostaglandin metabolism
(Konheim and Wolford, 2003; Wolford et al., 2003). A second QTL for early glucose
response mapped on Chr2 (Figure 6C). Several genes known to be involved in insulin
secretion or type 1 diabetes susceptibility are located under this peak, including paired box 6
(Pax6), Cd44, and catalase (Cat) (Chen et al., 2005; Jiang et al., 2011;Wen et al., 2009).
When blood glucose is measured from mice under fasting conditions, only a single locus is
mapped on Chr7 (Figure 6C). Although there are 91 genes under the locus, no gene was
previously linked to fasting glucose levels in mice or in humans. Finally, the global AUC is
strongly associated with the QTL located on Chr9 (Figure 6C). This region contains 31
genes, including one that has also been linked with insulin secretion: plasma membrane-
related Ca2+-ATPase-1 (Atp2c1) (Mitchell et al., 2004).
Functional analysis of the three QTLs related to glucose response on Chr1, 2, and 9
uncovered six genes known to be involved in glucose regulation. However, these QTLs
contain altogether 131 genes, many of which are not yet characterized. Therefore, we
highlighted potential new candidates by finding the strongest mRNA correlates in liver
(Figure 6D). From the list of the 500 best correlates, we selected candidates from three
categories: (1) genes located under the QTLs on Chr1, 2, and 9; (2) genes that have trans-
QTLs mapping to these loci; and (3) the five top gene correlates with glucose response. The
most significant matches were integrated into the network (Figure 6D). Protein phosphatase
1 regulatory subunit 3B (Ppp1r3b), a protein that regulates hepatic glycogen synthesis
(Kelsall et al., 2009), Myc, which plays a role in hepatic glucose uptake and utilization (Riu
et al., 1996), STE20-related kinase adaptor beta (Stradb), and Rab6b, correlated exclusively
with AUC (Figure 6D). In contrast, the rest of the candidates were entangled in an intricate
network revolving around the AUC (Mtf2, Slco4a1, BC030417, Srfs6, Gip, Wapal, Clic4,
Arpc5, Rin3, Omt2b, and BC003331) (Figure 6D). Among these genes, Sfrs6 and Gip have
also been linked with glucose homeostasis (Fossey et al., 2001;Lyssenko et al., 2011).
Andreux et al. Page 6
Cell. Author manuscript; available in PMC 2013 March 21.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Energy Expenditure Networks Link to Underlying mRNA Expression Differences
The volumes of oxygen consumed (VO2) and CO2 exhaled (VCO2) give an indirect
measurement of mitochondrial function in vivo—another key complex metabolic phenotype
(Auwerx, 2006; Tschöp et al., 2012). The respiratory exchange ratio (RER), defined as
VCO2/VO2, is an indirect measurement of the primary energy substrate used by the
organism, e.g., fats, proteins, or carbohydrates. Together, these parameters provide a
window on global energy homeostasis. In contrast to ALPL and glucose response, the
overall variation in these three parameters was quite modest (Figure 7A). Furthermore, these
traits had only average heritability (Figure 1D). Males and females did not have significantly
different energy expenditure, and the phenotypes were not significantly correlated by strain
(Figures S5A and S5B). Despite these modest indicators of genetic influence, these traits
mapped significantly and suggestively to five distinct QTLs (Figure 7B).
Similar to glucose response mapping, common QTLs were observed, with VO2 and VCO2
containing overlapping peaks on Chr1, 4, and 11. Somewhat surprisingly, RER maps to
separate QTLs on Chr10 and Chr15 (Figure 7B). All 441 genes under the five peaks were
analyzed for functional relationships to energy expenditure. Several genes closely related to
mitochondrial function were identified under the QTLs (Figure 7B), for example ATP
synthase H+ transporting mitochondrial F0 complex subunit G (Atp5l) and mitochondrial
ribosomal protein 54 (Mrpl54) (Figure 7B) (Pagliarini et al., 2008). Several candidates
related to fat metabolism were also identified, including aldehyde oxidase 1 (Aox1) and
activating transcription factor 4 (Atf4, also known as Creb2) (Seo et al., 2009; Weigert et al.,
2008).
All positional candidates were subsequently analyzed for covariation with VO2, VCO2, and
RER in order to identify potential candidates that were not yet reported in literature. This
was done by using an extensive BXD microarray database of whole-eye mRNA (Geisert et
al., 2009), a tissue containing a variety of cell types, including neurons and both glycolytic
and oxidative muscle. The network analysis of the 441 genes under the RER, VO2, and
VCO2 QTLs narrowed the list to four genes tightly covarying with the phenotypes:
aquaporin 3 (Aqp3), ubiquitin-conjugating enzyme E2R 2 (Ube2r2), cAMP responsive
element binding protein 3 (Creb3), and protein inhibitor of activated STAT 4 (Pias4) (Figure
7C). Aqp3 and Pias4 are negative correlates of RER, whereas Ube2r2 and Creb3 are positive
correlates of VO2 and VCO2 (Figure 7C). As of yet, none of these genes have been clearly
linked to respiration or mitochondrial function. However, these candidates belong to gene
families with clear ties, suggesting a functional, yet hitherto unknown relationship (further
connections and references described in Figure S5C).
To expand the small network of positional candidates, the top 500 expression correlates with
each trait were calculated and the top 10 correlates added into the network (Figure 7D). This
network indicated that although VO2 and VCO2 are tightly correlated and share QTLs,
several of the most significantly correlated genes, like profilin 1 (Pfn1), phosphatidylinositol
3-kinase, regulatory subunit 1 (Pik3r1), and aryl hydrocarbon receptor repressor (Ahrr),
were linked to VCO2 exclusively (Figure 7D). RER also presented exclusive correlates, such
as dual specificity phosphatase 10 (Dusp10) and acyl-CoA dehydrogenase family, member 9
(Acad9). Although on first thought it may be surprising that RER does not network closely
with VO2 and VCO2, RER is a weight-independent measurement of metabolic flexibility.
The common nodes that link VO2 or VCO2 with RER, such as protein kinase C alpha
(Prkca), pantothenate kinase 1 (Pank1), and kinesin family member 4 (Kif4) have clear
relevance to energy regulation (Leitges et al., 2002). Importantly, the only gene significantly
linked to all energy expenditure phenotypes, Kif4, could affect metabolism due to its
regulation of poly ADP-ribose polymerase 1 (Parp1) (Bai et al., 2011; Midorikawa et al.,
2006). Parallel network analysis using the same analytical technique in liver showed many
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similar top candidates, notably including Pank1 and Kif4, which are also linked in the eye
network to VO2 or VCO2 with RER (Figure S5D).
DISCUSSION
One of the main challenges in biomedical research is determining how genetic factors
interact to influence human health-span and how to develop effective strategies for the
diagnosis, prevention, and treatment of chronic multifactorial metabolic diseases. Studies in
model organisms often focus on single genes, which allows for precise mechanistic
dissection of individual pathways yet lacks the same level of real-world genetic complexity
behind variation in metabolic traits. This can compromise the generality and the translational
utility of findings. One of the first systems for studying complex systems was to use F2
intercrosses, which can be quickly generated. However, unless an F2 cross is large (n > 500)
it will generally have modest mapping resolution (>20 Mb). Yet the more serious limitation
is that F2 studies cannot be easily replicated or extended because each organism is
genetically unique. To address this problem and to produce more robust models for systems
genetics approaches, GRPs have been developed such as the BXD strains, currently the
largest available mammalian GRP. The BXDs constitute a reproducible and high-resolution
mapping panel with ~5 million segregating variants, similar to human populations (Altshuler
et al., 2010). Perhaps the most important longterm advantage of RI families is that it is
possible to accumulate huge electronic “health care” records for each of the genotypes under
different conditions and across many scales of biological organization. Technical error,
batch effects, laboratory environmental effects, and other issues can be detected, controlled,
and even exploited simply by expanding the number of strains or animals used.
When using GRPs, statistical power and mapping precision are mainly a function of the
number of genotypes that are included in a study. For the metabolic phenotypes measured
here, nongenetic variation within a genotype is generally low compared to variation across
genotypes, demonstrating high heritability in a standard vivarium environment. Essentially
all measured traits have sufficient heritable variation to motivate detailed genetic and QTL
analyses. Nearly half of the metabolic phenotypes differed significantly between sexes, thus
metabolic traits do not generalize reliably from one sex to the other. However, rather than
confining analysis to only one sex, balanced and interleaved sampling of both sexes may
offer more benefit.
A total of 140 metabolic traits were analyzed, of which 39 had significant peak QTLs and an
additional 15 had suggestive peak QTLs. The strongest QTLs are for expression phenotypes
and Mendelian-like classical phenotypes. The most significant QTL, ALPL expression, was
clearly linked to the Alpl gene and caused by two amino acid changes in evolutionary
conserved residues—R318Q and L324P—which are predicted to change the 3D structure
and activity of the ALPL protein. Presence of these mutations in carriers of the B allele
closely mimics downstream phenotypes of the human disorder hypophosphatasia, primarily
the strong increase in extracellular PLP levels, which along with ALPL levels provides the
most precise biomarker of hypophosphatasia (Whyte, 2000). One prominent downstream
effect of ALPL is its effect on promoting bone mineralization by hydrolyzing inorganic
pyrophosphate (PPi), an inhibitor of hydroxyapatite formation, into inorganic phosphate.
Consistent with this hypothesis, mice with the B allele had significantly reduced bone
volume and surface area. These observation have important translational value, as Alpl
coding variants are known to contribute to heritable differences in bone metabolism in
humans (Nielson et al., 2011).
Most metabolic traits are, however, complex and map to multiple loci. For example, glucose
response levels are associated with three loci and collectively contain six established
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positional candidates. Three of these candidates—Cd44, Cat, and Pax6—are located in the
Chr2 locus and linked to insulin secretion or type I diabetes. In line with this linkage, a large
F2 cross study of basal insulin levels also revealed a QTL on the same region (Mehrabian et
al., 1998). Studies in humans have identified only a single insulin sensitivity gene (PPARγ
[Deeb et al., 1998]), yet GWAS have identified several genes that control insulin secretion
(McCarthy, 2010). In addition to those identified genes that are clear candidates for glucose
response, it is possible, even likely, that other genes under these loci also influence glucose/
insulin response.
Genetic mapping of the energy expenditure traits yields five distinct QTLs containing over
400 positional candidate genes, including established genes in oxidative metabolism in two
general categories: those tied to general mitochondrial function (e.g., Mrpl54 and Atp5l) and
those tied to the regulation of lipid metabolism (e.g., Aox1 and Atf4). Atp5l is a component
of the complex V ATP synthesis machinery in oxidative phosphorylation, whereas Mrpl54 is
part of the mitochondrial ribosome responsible for the translation of the 13 proteins encoded
by the mitochondrial genome that are key components of the electron transport chain
(Pagliarini et al., 2008). From the other angle, Aox1 is involved in lipid metabolism and
produces reactive oxygen species as byproducts (Weigert et al., 2008) that are known to
affect respiration (Balaban et al., 2005). Atf4 (aka Creb2) is an established regulator of lipid
and energy homeostasis (Seo et al., 2009).
By combining QTL mapping with network building, it becomes practical to expand the
phenotype and positional candidate networks to highlight intriguing candidates genes that
are good targets for mechanistic studies of glycaemia and energy expenditure. For example,
the serine/arginine-rich splicing factor 6 (Sfrs6) is among the top correlates of glucose
response, and it is associated with type 2 diabetes susceptibility in humans (Fossey et al.,
2001). Many other relevant genes appear as top correlates when networks are extended
further. The glucose-dependent insulinotropic polypeptide (Gip) is only vicariously
connected to the phenotypes, but it has a strong functional relation: it promotes pancreatic
islet function and exerts pro-survival actions in humans (Lyssenko et al., 2011).
As with glucose response, network identification of the top mRNA correlates with the
phenotype revealed a mélange of genes involved in different aspects of energy regulation.
For example, the only significant correlate of all three parameters, Kif4, regulates PARP1,
the major NAD+ consuming enzyme in the cell (Houtkooper et al., 2010). PARP1 critically
controls oxidative metabolism due to its competition with SIRT1 for a common and limiting
NAD+ pool in the cell (Bai et al., 2011). Acad9, linked with RER, is essential for complex I
assembly via its impact on Ndufa1 and Ecsit (Haack et al., 2010; Nouws et al., 2010).
However, other genes without known ties to lipid or glucose metabolism also appeared as
top correlates, for example Ahrr and Pfn1.
In terms of building and testing models of complex processes such as metabolism, even
traits with low heritability or without strong QTLs provide great value. For instance,
although VCO2 is not linked to unique QTLs, its inclusion in network analysis not only
strengthens the common interacting genes with VO2, but also uncovers unique genes, which
may be novel to the phenotype. Likewise, the integration of gene expression from liver to
the glucose tolerance network increases the power to identify genes that are specific to one
organ function—in this case hepatic glucose metabolism. For both analyses, it is likely that
more novel genes involved in glucose response and energy expenditure remain under the
loci described. Such network construction underscores the usefulness of the BXD GRP as a
powerful resource for hypothesis generation and validation in a field as complex as
metabolism. Further complementary phenotypic measurements of the BXDs under
challenged conditions may help refine these regulatory pathways.
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Most analyses in this resource—including all of Figures 6 and 7—can be generated entirely
with public access to www.genenetwork.org. The phenotypes from this study can be found
under BXD phenotypes by searching for “LISP1” and either analyzed on-site or downloaded
for separate analysis. A wide variety of public microarray data and phenotype data from
other studies on the same BXD strains are also available for translational analyses on
GeneNetwork. Together this makes the BXDs among the largest and best-categorized family
of isogenic strains, and we expect resources like this to serve as the back-bone for murine
studies on complex disease for the coming decade.
EXPERIMENTAL PROCEDURES
Animals
We acquired 25 BXD strains of females and 42 BXD strains of males from the University of
Tennessee Health Science Center (Memphis, TN, USA). Strains and sexes were housed
together with two to four animals per cage under 12 hr light, 12 hr dark cycle with ad
libitum access to water and chow diet food (D04, SAFE, Augy, France) at all times. The
studies shown in Figure 5 were carried out in a subset of these strains at a significantly older
age (40–52 weeks) than the animals in the primary study protocol (8–20 weeks).
General Study Plan and Phenotyping tests
The general outline of the phenotyping study is described in the results section and
summarized in Figure 1C. All tests were carried out according to rigorous standard
operating procedures (SOP) established and validated within the EUMODIC EMPReSS
program (Champy et al., 2004; Champy et al., 2008).
Bioinformatics and Statistical Analysis
R was used for the analysis of phenotypic data, and GeneNetwork (www.genenetwork.org)
was used for all genetic analyses (Chesler et al., 2004). Student’s t test was used to calculate
significance between males and females. Pearson’s r and p values were calculated to
determine magnitude and significance of correlations except when otherwise indicated.
Correlation networks and QTL calculations are Bonferroni-corrected for multiple testing.
The y axes of bar graphs are often cropped to highlight strain differences.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Study Design for Identifying Genetic Loci that Control Metabolic Traits
(A) The BXD lines were created by crossing B and D parents. The resulting heterozygous
F1 mice were again crossed to generate genetically diverse but nonreproducible F2 animals.
These F2 progeny were iteratively inbred until generation F20+, at which point the genome
was 99.5+% isogenic and the strains are considered fully inbred and together constitute a
GRP. The ~160 BXD strains are numbered 1–183.
(B) Top: power depends mainly on strain number instead on number of mice/strain.
Calculations are for a trait variance fixed at 33%. Bottom: the power to detect a given
fraction of variance with a single QTL. Power was calculated with cohort size fixed at four.
Both calculations were done for a trait with heritability of 0.67.
(C) All animals underwent the same phenotyping programs as specified in the result section.
The age corresponds to the timing of the phenotype experiment. BXD60 was only
phenotyped in females—all other female strains overlapped with male strains.
(D) Heritability of select traits from each phenotyping group. Traits discussed in-depth in
this resource paper are indicated in black. Traits are grouped according to phenotyping test.
“Body Composition” represents echocardiography phenotypes, bone size, bone density, and
body weight.
(E) The analysis flow-chart. The cause-to-consequence effect reads from top to bottom. A
SNP induces a change in the expression or function of a candidate gene, which has an
impact on a given downstream effect or phenotype.
Related to Figure S1.
Andreux et al. Page 15
Cell. Author manuscript; available in PMC 2013 March 21.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Figure 2. Strain and Sex Influences Differ Widely between Parameters
(A) Metabolic phenotype variation for all cohorts.
(B) Traits with higher variation were more likely to have significant differences between
males and females; 41% of traits are significantly different (traits on the x axis lower than
rank 22).
(C) Example of a sex-independent trait that is mostly determined by environment: the
ventricular shortening fraction.
(D) Example of a sex-independent trait that is mostly determined by genetics: the mean cell
volume of red blood cells.
(E) Example of a sex-influenced trait that is explained by a mix of genetic and
environmental factors: body weight at 18 weeks. Bar graphs and X-Y plots are expressed as
mean + SEM.
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Figure 3. Analysis of Peak Trait QTLs
(A) The genetic variation attributable to a QTL is calculated by the correlation between the
trait values (here, ALPL levels) and the genotype at the peak location. ALPL has only one
QTL, which explains 58% of the genetic variation.
(B) The genetic variation attributable to each of the three QTLs mapped to oxygen
consumption. Each QTL has a much smaller effect, but together account for a large amount
of variation. Generalized linear modeling or ANOVA (used here) is necessary to calculate
the variation independently attributable to each QTL for traits which map to multiple QTLs.
(C) The LOD score, corrected p value, and QTL peak location are given along with the trait
for the top 10 distinct phenotypes. Of note, this is not all of the significant or suggestive
peaks for each trait; only the most significant peak is listed. One positional candidate is
given for traits when a literature analysis of every gene under each peak has yielded a linked
result. Candidates not discussed in the text include the link between white blood cells and
Irak-M (Xie et al., 2007), Pten and heart rate (Zu et al., 2011), and RER in females and
Bckdh (Joshi et al., 2006). Systolic BP LOD score is for analysis as described in
(Koutnikova et al., 2009). A list of all 54 traits with suggestive or significant peak QTLs is
available in Table S1.
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Figure 4. Reducing the ALPL QTL to Its Causative Mutation between DBA and C57 Alleles
(A) Expression variation of serum ALPL activity and mRNA levels from liver transcriptome
data. Strains with the D allele (red) have significantly more ALPL protein and Alpl mRNA
than strains with the B allele (white) for all comparisons (p < 0.005). Males have
significantly less ALPL protein than females, but there is no difference in mRNA levels.
(B) Correlation between male and female Alpl mRNA and ALPL protein levels demonstrate
high trait heritability (Figure 1D).
(C) QTL map for liver Alpl mRNA and blood ALPL levels in males and females. All four
QTLs (male and female traits are mapped separately) mapped to the same location and
crossed the significance threshold of p < 0.05, indicated by the red horizontal line. The Alpl
gene is located below the rectangular peak at right.
(D) 3D model of ALPL from Phyre2, based on the crystal structure of the placental form of
ALP (ALPP). Enlarged on the right are the structure of the amino acids flanking and
including the two missense mutations (noted in green).
(E) Forty-four amino acid excerpt of sequence comparison of orthologs of ALPL, the amino
acid sequence of the region modeled in (D) is shown here. The full protein sequence is
highly conserved in mammals (>90% homology) and moderately from mammals to bacteria
(>30% homology).
(F) Phylogenetic tree of Alpl. The gene has orthologs in all known species, notably
including invertebrates. Bar graphs and X-Y plots are expressed as mean+SEM. Related to
Figure S2.
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Figure 5. Clinical Phenotyping of Mice with Extreme Alkaline Phosphatase Values
(A) ALPL levels in all individuals in a further in-depth study in male and female mice for
individuals from the 11 strains described in the text. The effect observed on serum ALPL
levels shown in Figure 4A was highly reproducible in this independent study, even given a
significant difference in the age of the animals in the two studies (19 weeks versus ~46
weeks).
(B) Extracellular PLP levels strongly negatively correlated with ALPL levels in males and
females. No correlations were observed between ALPL and extracellular PL, but the ratio of
extracellular PLP/PL was also strongly negatively correlated with ALPL.
(C) Bone volume and surface area were significantly decreased in animals with the B allele
of Alpl, consistent with the hypothesis of hypophosphatasia in the strains with the B allele.
(D) Scheme summarizing the multiple roles of ALPL in metabolism. Before entering
tissues, pyridoxal-5′-phosphate (PLP) in the plasma must be dephosphorylated by ALPL
into pyridoxal (PL), which can traverse cell membranes. PL is converted back into PLP by
the pyridoxine kinase (PDXK) in the target tissues, such as liver or brain. PLP is a cofactor
in many enzymatic reactions. Circulating ALPL also converts pyrophosphate (PPi) into
inorganic phosphate (Pi). Although PPi inhibits bone mineralization, Pi and calcium (Ca2+)
stimulate it. Low levels of ALPL activity disrupt proper bone development and remodeling
via this mechanism.
Related to Figure S3.
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Figure 6. Analysis of Response to an Intraperitoneal Glucose Tolerance Test
(A) Variation of the AUC of the glucose levels from 0 to 120 min.
(B) Network of glucose tolerance response determinants in males and females. Full details
are given in Table S2.
(C) Multiple and single QTL heat map for glucose levels at each time point. Loci switch
according to the feeding status of the mice. Fasting glucose (t = 0 min) maps appear only on
Chr7. The early response to glucose injection (t = 15 min) maps on Chr2 only, whereas the
rest of the time points also map on Chr1 and Chr9. Candidates under each QTL were
selected according to existing literature showing their link with type 2 or type 1 diabetes.
Further details are given in Figure S4.
(D) Network built around overall glucose response by using gene expression in the liver.
Among the top 500 liver mRNA correlates with AUC, two were located on Chr1 QTL
(Arpc5 and BC003331) and one on Chr9 QTL (Rab6b) (yellow boxes). One gene had a
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transQTL on the Chr1 QTL (Ppp1r3b), four had transQTLs on the Chr2 QTL (Sfrs6, Clic4,
Slco4a1 and Mtf2), and one had a transQTL on the Chr9 QTL (Gip) (yellow boxes). Light
blue boxes are attributed to the five genes that best correlated with AUC (Wapal, Rin3,
Omt2b, Stradb and Myc). Bold dark blue lines represent −1 < r < −0.7, light blue lines −0.7
< r < −0.5, light orange lines 0.5 < r < 0.7 and bold red lines 0.7 < r < 1.
Related to Figure S4 and Table S2.
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Figure 7. Regulatory Network Underlying Differences in Respiration
(A) Variation among male strains of BXD mice in three parameters of respiration: VO2,
VCO2, and RER. Variation across and correlation with female strains is given in Figure S3.
(B) QTL graphs of the three respiratory parameters, VO2 (blue), VCO2 (red), and RER
(green). Significance is shown by the red horizontal line, suggestive by the blue line (LOD >
3.3 and 3.0, respectively). Candidate genes with established links to energy expenditure are
listed below the locus (Aox1, Atp5l, Creb3, Ube2r2, Aqp3, Mrpl54, Pias4, Tab1, and Atf4).
(C) Network graph showing all positional candidates with mRNA expression that correlates
significantly with the phenotypes in whole-eye tissue (Geisert et al., 2009).
(D) Expanded network graph using the same data set, including the top ten mRNA correlates
of the phenotypes (light blue boxes). Interestingly, RER had the strongest top mRNA
correlates (Acad9, Dusp10, and Adar), whereas Kif4 was the only significant correlate of all
three parameters, and the only strong (|r| > 0.7) mRNA correlate to VO2 and none were
observed for VCO2. Prkca and Mgat4a were shared significantly between two parameters.
Despite the strong correlation between VO2 and VCO2, most top correlates were not shared.
Bold dark blue lines represent −1 < r < −0.7, light blue lines −0.7 < r < −0.5, light orange
lines 0.5 < r < 0.7 and bold red lines 0.7 < r < 1. Bar graphs are expressed as mean + SEM.
Related to Figure S5.
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